Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05887973 · ClinicalTrials.gov registry record
Addressing Root Causes for Gun Violence Prevention (ARC-GVP)
A clinical trial of Aggression and Violence, sponsored by University of Michigan.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT05887973: Recruiting study of Aggression and Violence, sponsored by University of Michigan.
NCT05887973 is a study of Aggression and Violence that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 250 participants, above the 143-participant average among 21 other Aggression trials with a reported enrollment target (75% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05887973, a study of Aggression and Violence, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to help build the evidence base for a locally-relevant youth firearm violence prevention program in Washington D.C., a city experiencing disparities in youth firearm violence outcomes. The main question it aims to answer is: How is youth participation in the summer youth employment program, the True Reasons I Grabbed the Gun Evolved from Risk (The T.R.I.G.G.E.R Project), which is designed to address root causes of gun violence, associated with individual youth behavioral outcomes, including pro-social involvement, aggression, and firearm-related attitudes and behaviors?
Primary Outcome
The investigators will assess change in civic efficacy (i.e., youth participants' sense of belief that they can create positive change in their communities) over time using the 3-item Civic Efficacy scale; the unit(s) of measurement are the Mean and Standard Deviation of scale scores; Minimum Value: 1 Maximum Value: 5, higher scores indicate a better outcome
Conditions Studied
Interventions
- BEHAVIORAL The T.R.I.G.G.E.R Project
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-06-27 |
| Est. Completion | 2026-07 |
What NCT05887973 shows while recruiting
NCT05887973 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 143-participant average among 21 other Aggression trials with a reported enrollment target (75% higher).
The record links to 4 conditions, with Aggression appearing as the primary indexed condition, and to 1 intervention - of which The T.R.I.G.G.E.R Project is the first listed.
NCT05887973 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05887973 about?
NCT05887973 is a clinical study titled "Addressing Root Causes for Gun Violence Prevention (ARC-GVP)". The goal of this study is to help build the evidence base for a locally-relevant youth firearm violence prevention program in Washington D.C., a city experiencing disparities in youth firearm violence outcomes. The main question it aims to answer is: How is youth participation in the summer youth ...
What is the current status of trial NCT05887973?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2022-06-27. Estimated completion is 2026-07.
What conditions does trial NCT05887973 study?
This clinical trial studies the following conditions: Aggression, Violence, Adolescent, Firearm Injury.
What interventions are being tested in trial NCT05887973?
The interventions under investigation include: The T.R.I.G.G.E.R Project (BEHAVIORAL).
Who is sponsoring clinical trial NCT05887973?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05887973 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aggression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05887973's enrollment target sits among peer trials
250 4th of 21 higher than 18 of 21 other Aggression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aggression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
Manualized Assessment and Treatment Model of Challenging Behavior
RECRUITING · NA
-
Refinements of Functional Communication Training
RECRUITING · NA
-
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
RECRUITING · Phase 2
-
Clinical Trial on Agitation in Alzheimer's Dementia
RECRUITING · Phase 2
-
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI